{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:26:12Z","timestamp":1794324372421,"version":"4.9.0"},"reference-count":124,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.rdc.2023.06.007","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T15:26:11Z","timestamp":1689953171000},"page":"895-911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis"],"prefix":"10.1016","volume":"49","author":[{"given":"Grant S.","family":"Schulert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kessel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.rdc.2023.06.007_bib1","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.rdc.2023.06.007_bib2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12969-015-0047-3","article-title":"Gene-expression analysis of adult-onset Still's disease and systemic juvenile idiopathic arthritis is consistent with a continuum of a single disease entity","volume":"13","author":"Nirmala","year":"2015","journal-title":"Pediatr Rheumatol Online J"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.007_bib3","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1136\/annrheumdis-2016-210324","article-title":"Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications","volume":"76","author":"Ombrello","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2023.06.007_bib4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.berh.2018.02.002","article-title":"Systemic juvenile idiopathic arthritis: New insights into pathogenesis and cytokine directed therapies","volume":"31","author":"Pardeo","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2023.06.007_bib5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.rdc.2021.06.003","article-title":"Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis: Refractory Arthritis, Recurrent Macrophage Activation Syndrome and Chronic Lung Disease","volume":"47","author":"Erkens","year":"2021","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.rdc.2023.06.007_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","article-title":"The Immunology of Macrophage Activation Syndrome","volume":"10","author":"Crayne","year":"2019","journal-title":"Front Immunol"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.007_bib7","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/acr.21889","article-title":"Pulmonary Hypertension and Other Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis","volume":"65","author":"Kimura","year":"2013","journal-title":"Arthrit Care Res"},{"issue":"9","key":"10.1016\/j.rdc.2023.06.007_bib8","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J\u00a0Exp Med"},{"issue":"2","key":"10.1016\/j.rdc.2023.06.007_bib9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/art.30128","article-title":"Anakinra as First-Line Disease-Modifying Therapy in Systemic Juvenile Idiopathic Arthritis Report of Forty-Six Patients From an International Multicenter Series","volume":"63","author":"Nigrovic","year":"2011","journal-title":"Arthritis Rheum-Us"},{"issue":"4","key":"10.1016\/j.rdc.2023.06.007_bib10","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/art.38296","article-title":"Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis Results of a Prospective Cohort Study","volume":"66","author":"Vastert","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2023.06.007_bib11","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1002\/art.40865","article-title":"Treat-to-target using first-line recombinant interleukin-1 receptor antagonist monotherapy in new-onset systemic juvenile idiopathic arthritis: results from a five year follow-up study","volume":"71","author":"Ter Haar","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2023.06.007_bib12","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1002\/art.38615","article-title":"Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis?","volume":"66","author":"Nigrovic","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"52","key":"10.1016\/j.rdc.2023.06.007_bib13","doi-asserted-by":"crossref","first-page":"15970","DOI":"10.1073\/pnas.1520779112","article-title":"HLA-DRB1\u221711 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis","volume":"112","author":"Ombrello","year":"2015","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.007_bib14","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/annrheumdis-2018-214354","article-title":"Machine learning identifies an immunological pattern associated with multiple juvenile idiopathic arthritis subtypes","volume":"78","author":"Van Nieuwenhove","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.rdc.2023.06.007_bib15","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/rheumatology\/kes162","article-title":"Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis","volume":"51","author":"Omoyinmi","year":"2012","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.007_bib16","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1002\/art.42409","article-title":"Aberrant naive CD4+ T\u00a0cell differentiation in systemic juvenile idiopathic arthritis is committed to B cell help","volume":"75","author":"Kuehn","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2023.06.007_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132508","article-title":"Th17 reprogramming of T\u00a0cells in systemic juvenile idiopathic arthritis","volume":"5","author":"Henderson","year":"2020","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.rdc.2023.06.007_bib18","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/art.40099","article-title":"Pro-inflammatory cytokine environments can drive IL-17 over-expression by gammadeltaT cells in systemic juvenile idiopathic arthritis","volume":"69","author":"Kessel","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"52","key":"10.1016\/j.rdc.2023.06.007_bib19","doi-asserted-by":"crossref","first-page":"15785","DOI":"10.1073\/pnas.1521837113","article-title":"Autoinflammation and autoimmunity in systemic juvenile idiopathic arthritis","volume":"112","author":"Nigrovic","year":"2015","journal-title":"P\u00a0Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.007_bib20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrrheum.2015.179","article-title":"Macrophage activation syndrome in the era of biologic therapy","volume":"12","author":"Grom","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.rdc.2023.06.007_bib21","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","article-title":"Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (\u2217)","volume":"27","author":"Masters","year":"2009","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"10.1016\/j.rdc.2023.06.007_bib22","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/art.40498","article-title":"IL1RN Variation Influences Both Disease Susceptibility and Response to Recombinant Human Interleukin-1 Receptor Antagonist Therapy in Systemic Juvenile Idiopathic Arthritis","volume":"70","author":"Arthur","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2023.06.007_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/art.41130","article-title":"Impact of IL1RN Variants on Response to Interleukin-1 Blocking Therapy in Systemic Juvenile Idiopathic Arthritis","volume":"72","author":"Hinze","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2023.06.007_bib24","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/art.41612","article-title":"Early Treatment and IL1RN Single-Nucleotide Polymorphisms Affect Response to Anakinra in Systemic Juvenile Idiopathic Arthritis","volume":"73","author":"Pardeo","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.007_bib25","doi-asserted-by":"crossref","first-page":"6915","DOI":"10.1038\/s41467-022-34480-6","article-title":"mTORC1 links pathology in experimental models of Still's disease and macrophage activation syndrome","volume":"13","author":"Huang","year":"2022","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.007_bib26","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/rheumatology\/37.5.562","article-title":"Inflammatory cytokines and cytokine antagonists in whole blood cultures of patients with systemic juvenile chronic arthritis","volume":"37","author":"Muller","year":"1998","journal-title":"Br J Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2023.06.007_bib27","first-page":"1670","article-title":"Abnormal regulation of interleukin 6 in systemic juvenile idiopathic arthritis","volume":"28","author":"Pignatti","year":"2001","journal-title":"J\u00a0Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2023.06.007_bib28","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s11926-005-0047-2","article-title":"The use of anakinra in juvenile arthritis","volume":"7","author":"Reiff","year":"2005","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.007_bib29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/art.38877","article-title":"Association of a mutation in LACC1 with a monogenic form of systemic juvenile idiopathic arthritis","volume":"67","author":"Wakil","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.rdc.2023.06.007_bib30","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/ni.3532","article-title":"C13orf31 (FAMIN) is a central regulator of immunometabolic function","volume":"17","author":"Cader","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.rdc.2023.06.007_bib31","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.clim.2016.05.010","article-title":"Cytokine profile in adult-onset Still's disease: Comparison with systemic juvenile idiopathic arthritis","volume":"169","author":"Inoue","year":"2016","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.007_bib32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41584-021-00590-6","article-title":"Biological classification of childhood arthritis: roadmap to a molecular nomenclature","volume":"17","author":"Nigrovic","year":"2021","journal-title":"Nat Rev Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.007_bib33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/BOR.0000000000000637","article-title":"Implications of juvenile idiopathic arthritis genetic risk variants for disease pathogenesis and classification","volume":"31","author":"Nigrovic","year":"2019","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2023.06.007_bib34","first-page":"2422","article-title":"Serum cytokine profiles in patients with adult onset Still's disease","volume":"30","author":"Choi","year":"2003","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.007_bib35","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/art.23437","article-title":"The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis","volume":"58","author":"Gattorno","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2023.06.007_bib36","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/art.40442","article-title":"Reversal of Sepsis-Like Features of Neutrophils by Interleukin-1 Blockade in Patients With Systemic-Onset Juvenile Idiopathic Arthritis","volume":"70","author":"Ter Haar","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2023.06.007_bib37","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1002\/art.24349","article-title":"The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis","volume":"60","author":"Frosch","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.rdc.2023.06.007_bib38","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1002\/art.24137","article-title":"S100A12 is a novel molecular marker differentiating systemic-onset juvenile idiopathic arthritis from other causes of fever of unknown origin","volume":"58","author":"Wittkowski","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2023.06.007_bib39","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.3389\/fimmu.2018.02995","article-title":"Neutrophils From Children With Systemic Juvenile Idiopathic Arthritis Exhibit Persistent Proinflammatory Activation Despite Long-Standing Clinically Inactive Disease","volume":"9","author":"Brown","year":"2018","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.007_bib40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/rheumatology\/keaa324","article-title":"Elevated circulating pro-inflammatory low-density granulocytes in adult-onset Still's disease","volume":"60","author":"Liu","year":"2021","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.rdc.2023.06.007_bib41","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/rheumatology\/kex441","article-title":"Neutrophil activation signature in juvenile idiopathic arthritis indicates the presence of low-density granulocytes","volume":"57","author":"Ramanathan","year":"2018","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.rdc.2023.06.007_bib42","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.3899\/jrheum.181058","article-title":"Neutrophil Extracellular Traps May Contribute to the Pathogenesis in Adult-onset Still Disease","volume":"46","author":"Ahn","year":"2019","journal-title":"J\u00a0Rheumatol"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.007_bib43","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/art.38359","article-title":"Systemic juvenile idiopathic arthritis-like syndrome in mice following stimulation of the immune system with freund's complete adjuvant: Regulation by interferon-\u03b3","volume":"66","author":"Avau","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2023.06.007_bib44","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1002\/art.42104","article-title":"Role for Granulocyte Colony-Stimulating Factor in Neutrophilic Extramedullary Myelopoiesis in a Murine Model of Systemic Juvenile Idiopathic Arthritis","volume":"74","author":"Malengier-Devlies","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2023.06.007_bib45","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.clim.2009.09.010","article-title":"Distribution of circulating cells in systemic juvenile idiopathic arthritis across disease activity states","volume":"134","author":"Macaubas","year":"2010","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.rdc.2023.06.007_bib46","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","article-title":"Transcriptome-based network analysis reveals a spectrum model of human macrophage activation","volume":"40","author":"Xue","year":"2014","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.rdc.2023.06.007_bib47","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.clim.2011.12.008","article-title":"Alternative activation in systemic juvenile idiopathic arthritis monocytes","volume":"142","author":"Macaubas","year":"2012","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.007_bib48","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/annrheumdis-2020-217470","article-title":"Monocyte and bone marrow macrophage transcriptional phenotypes in systemic juvenile idiopathic arthritis reveal TRIM8 as a mediator of IFN-gamma hyper-responsiveness and risk for macrophage activation syndrome","volume":"80","author":"Schulert","year":"2021","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.rdc.2023.06.007_bib49","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1002\/art.39694","article-title":"Monocyte MicroRNA Expression in Active Systemic Juvenile Idiopathic Arthritis Implicates MicroRNA-125a-5p in Polarized Monocyte Phenotypes","volume":"68","author":"Schulert","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"11","key":"10.1016\/j.rdc.2023.06.007_bib50","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1002\/art.22981","article-title":"Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome","volume":"56","author":"Fall","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2023.06.007_bib51","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/art.22416","article-title":"The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis","volume":"56","author":"Bleesing","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.rdc.2023.06.007_bib52","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1084\/jem.20170412","article-title":"A\u00a0multidimensional blood stimulation assay reveals immune alterations underlying systemic juvenile idiopathic arthritis","volume":"214","author":"Cepika","year":"2017","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.rdc.2023.06.007_bib53","article-title":"Changes in MiR-17-92 Cluster Expression Link Systemic Juvenile Idiopathic Arthritis, Monocyte-to-Macrophage Differentiation, and Interferon Regulation","volume":"71","author":"Takellapti","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.rdc.2023.06.007_bib54","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/s41590-021-00928-y","article-title":"Repression of CTSG, ELANE and PRTN3-mediated histone H3 proteolytic cleavage promotes monocyte-to-macrophage differentiation","volume":"22","author":"Cheung","year":"2021","journal-title":"Nat Immunol"},{"issue":"11","key":"10.1016\/j.rdc.2023.06.007_bib55","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1002\/art.34604","article-title":"The limited role of interferon-gamma in systemic juvenile idiopathic arthritis cannot be explained by cellular hyporesponsiveness","volume":"64","author":"Sikora","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.rdc.2023.06.007_bib56","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.clim.2015.12.011","article-title":"Altered signaling in systemic juvenile idiopathic arthritis monocytes","volume":"163","author":"Macaubas","year":"2016","journal-title":"Clin Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.007_bib57","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/annrheumdis-2015-209020","article-title":"Elevated circulating levels of interferon-gamma and interferon-gamma-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"76","author":"Bracaglia","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.rdc.2023.06.007_bib58","doi-asserted-by":"crossref","first-page":"E563","DOI":"10.1016\/S2665-9913(21)00115-6","article-title":"Definition and validation of serum biomarkers for optimal differentiation of hyperferritinaemic cytokine storm conditions in children: a retrospective cohort study","volume":"3","author":"Kessel","year":"2021","journal-title":"Lancet Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2023.06.007_bib59","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.clim.2012.11.008","article-title":"Phagocyte-derived S100 proteins in autoinflammation: putative role in pathogenesis and usefulness as biomarkers","volume":"147","author":"Kessel","year":"2013","journal-title":"Clin Immunol"},{"issue":"7","key":"10.1016\/j.rdc.2023.06.007_bib60","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1093\/rheumatology\/keab729","article-title":"MRP8\/14 serum levels as diagnostic markers for systemic juvenile idiopathic arthritis in children with prolonged fever","volume":"61","author":"Park","year":"2022","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.rdc.2023.06.007_bib61","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/annrheumdis-2011-200598","article-title":"The Toll-like receptor 4 agonist MRP8\/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis","volume":"71","author":"Holzinger","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.007_bib62","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1172\/JCI89867","article-title":"Autoinhibitory regulation of S100A8\/S100A9 alarmin activity locally restricts sterile inflammation","volume":"128","author":"Vogl","year":"2018","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.rdc.2023.06.007_bib63","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.jaci.2018.06.027","article-title":"Calcium and zinc tune autoinflammatory toll-like receptor 4 signaling by S100A12","volume":"142","author":"Kessel","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.007_bib64","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/art.40784","article-title":"Monocyte-Derived Interleukin-1beta As the Driver of S100A12-Induced Sterile Inflammatory Activation of Human Coronary Artery Endothelial Cells: Implications for the Pathogenesis of Kawasaki Disease","volume":"71","author":"Armaroli","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2023.06.007_bib65","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.4049\/jimmunol.158.4.1541","article-title":"IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12","volume":"158","author":"Kohno","year":"1997","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.007_bib66","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1038\/s41467-018-05489-7","article-title":"T\u00a0cell-intrinsic IL-1R signaling licenses effector cytokine production by memory CD4 T\u00a0cells","volume":"9","author":"Jain","year":"2018","journal-title":"Nat Commun"},{"issue":"8","key":"10.1016\/j.rdc.2023.06.007_bib67","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.4049\/jimmunol.178.8.5271","article-title":"Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1beta and IL-18 release","volume":"178","author":"Li","year":"2007","journal-title":"J\u00a0Immunol"},{"issue":"4","key":"10.1016\/j.rdc.2023.06.007_bib68","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1365-2567.2001.01337.x","article-title":"Interleukin-1 beta, but not interleukin-1 alpha, is required for T-cell-dependent antibody production","volume":"104","author":"Nakae","year":"2001","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.007_bib69","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4049\/jimmunol.167.1.90","article-title":"IL-1 enhances T\u00a0cell-dependent antibody production through induction of CD40 ligand and OX40 on T\u00a0cells","volume":"167","author":"Nakae","year":"2001","journal-title":"J\u00a0Immunol"},{"issue":"10","key":"10.1016\/j.rdc.2023.06.007_bib70","doi-asserted-by":"crossref","first-page":"6141","DOI":"10.4049\/jimmunol.162.10.6141","article-title":"IL-1 is an effective adjuvant for mucosal and systemic immune responses when coadministered with protein immunogens","volume":"162","author":"Staats","year":"1999","journal-title":"J\u00a0Immunol"},{"issue":"15","key":"10.1016\/j.rdc.2023.06.007_bib71","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aan0368","article-title":"T(fr) cells lack IL-2Ralpha but express decoy IL-1R2 and IL-1Ra and suppress the IL-1-dependent activation of T(fh) cells","volume":"2","author":"Ritvo","year":"2017","journal-title":"Sci Immunol"},{"issue":"6013","key":"10.1016\/j.rdc.2023.06.007_bib72","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.rdc.2023.06.007_bib73","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3109\/08830185.2013.783831","article-title":"Gammadelta T\u00a0cells: innately adaptive immune cells?","volume":"32","author":"Ferreira","year":"2013","journal-title":"Int Rev Immunol"},{"issue":"2","key":"10.1016\/j.rdc.2023.06.007_bib74","first-page":"239","article-title":"Different circulating lymphocyte profiles in patients with different subtypes of juvenile idiopathic arthritis","volume":"20","author":"Wouters","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.rdc.2023.06.007_bib75","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.3389\/fimmu.2019.03089","article-title":"Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome","volume":"10","author":"Vandenhaute","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.007_bib76","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/art.39933","article-title":"Inflammatory Gene Expression Profile and Defective Interferon-gamma and Granzyme K in Natural Killer Cells From Systemic Juvenile Idiopathic Arthritis Patients","volume":"69","author":"Put","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2023.06.007_bib77","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/rheumatology\/keg074","article-title":"Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation","volume":"42","author":"Wulffraat","year":"2003","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.rdc.2023.06.007_bib78","doi-asserted-by":"crossref","first-page":"781","DOI":"10.4049\/jimmunol.1100789","article-title":"Unexpected role for granzyme K in CD56bright NK cell-mediated immunoregulation of multiple sclerosis","volume":"187","author":"Jiang","year":"2011","journal-title":"J\u00a0Immunol"},{"issue":"9","key":"10.1016\/j.rdc.2023.06.007_bib79","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1002\/art.24750","article-title":"Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis","volume":"60","author":"de Jager","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.rdc.2023.06.007_bib80","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1002\/art.39295","article-title":"Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome","volume":"67","author":"Cifaldi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.rdc.2023.06.007_bib81","first-page":"S1","article-title":"Identification of a novel pro-inflammatory human skin-homing V gamma 9V delta 2 T\u00a0cell subset and its role in the pathogenesis of psoriasis","volume":"131","author":"Laggner","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"issue":"10","key":"10.1016\/j.rdc.2023.06.007_bib82","doi-asserted-by":"crossref","first-page":"5738","DOI":"10.4049\/jimmunol.1003597","article-title":"Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T\u00a0cells that mediate autoimmunity","volume":"186","author":"Lalor","year":"2011","journal-title":"J\u00a0Immunol"},{"issue":"3","key":"10.1016\/j.rdc.2023.06.007_bib83","first-page":"287","article-title":"Effect of IL-18 on expansion of gammadelta T\u00a0cells stimulated by zoledronate and IL-2","volume":"33","author":"Li","year":"2010","journal-title":"J\u00a0Immunother"},{"issue":"11","key":"10.1016\/j.rdc.2023.06.007_bib84","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1172\/JCI20742","article-title":"TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice","volume":"114","author":"Horai","year":"2004","journal-title":"J\u00a0Clin Invest"},{"issue":"4","key":"10.1016\/j.rdc.2023.06.007_bib85","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.4049\/jimmunol.1300387","article-title":"Excess IL-1 Signaling Enhances the Development of Th17 Cells by Downregulating TGF-beta-Induced Foxp3 Expression","volume":"192","author":"Ikeda","year":"2014","journal-title":"J\u00a0Immunol"},{"issue":"11","key":"10.1016\/j.rdc.2023.06.007_bib86","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.15252\/embr.201744200","article-title":"IL-23 drives differentiation of peripheral gammadelta17 T\u00a0cells from adult bone marrow-derived precursors","volume":"18","author":"Papotto","year":"2017","journal-title":"EMBO Rep"},{"issue":"2","key":"10.1016\/j.rdc.2023.06.007_bib87","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/clin.1997.4457","article-title":"A\u00a0mixed Th1\/Th2 cell cytokine response predominates in systemic onset juvenile rheumatoid arthritis: Immunoregulatory IL-10 function","volume":"86","author":"Raziuddin","year":"1998","journal-title":"Clin Immunol Immunopathol"},{"issue":"13","key":"10.1016\/j.rdc.2023.06.007_bib88","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","article-title":"Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome","volume":"131","author":"Weiss","year":"2018","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.rdc.2023.06.007_bib89","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/rheumatology\/keu524","article-title":"Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-gamma","volume":"54","author":"Put","year":"2015","journal-title":"Rheumatology"},{"key":"10.1016\/j.rdc.2023.06.007_bib90","doi-asserted-by":"crossref","first-page":"642778","DOI":"10.3389\/fimmu.2021.642778","article-title":"Lung Functioning and Inflammation in a Mouse Model of Systemic Juvenile Idiopathic Arthritis","volume":"12","author":"Malengier-Devlies","year":"2021","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.rdc.2023.06.007_bib91","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41584-021-00694-z","article-title":"Targeting interferon-gamma in hyperinflammation: opportunities and challenges","volume":"17","author":"De Benedetti","year":"2021","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2023.06.007_bib92","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.clim.2008.12.008","article-title":"IL-1 beta and IL-2 convert human Treg into T(H)17 cells","volume":"131","author":"Deknuydt","year":"2009","journal-title":"Clin Immunol"},{"issue":"9","key":"10.1016\/j.rdc.2023.06.007_bib93","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/ni1488","article-title":"IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways","volume":"8","author":"Zhou","year":"2007","journal-title":"Nat Immunol"},{"issue":"11\u201312","key":"10.1016\/j.rdc.2023.06.007_bib94","doi-asserted-by":"crossref","first-page":"552","DOI":"10.2119\/molmed.2010.00067","article-title":"Interleukin-1beta and interleukin-6 in arthritis animal models: roles in the early phase of transition from acute to chronic inflammation and relevance for human rheumatoid arthritis","volume":"16","author":"Ferraccioli","year":"2010","journal-title":"Mol Med"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.007_bib95","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/imr.12040","article-title":"Transcriptional regulation of follicular T-helper (Tfh) cells","volume":"252","author":"Liu","year":"2013","journal-title":"Immunol Rev"},{"issue":"3","key":"10.1016\/j.rdc.2023.06.007_bib96","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41423-020-00529-z","article-title":"Shared and distinct roles of T peripheral helper and T follicular helper cells in human diseases","volume":"18","author":"Yoshitomi","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.007_bib97","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/art.41913","article-title":"Effect of Clonally Expanded PD-1(high) CXCR5-CD4+ Peripheral T Helper Cells on B Cell Differentiation in the Joints of Patients With Antinuclear Antibody-Positive Juvenile Idiopathic Arthritis","volume":"74","author":"Fischer","year":"2022","journal-title":"Arthritis Rheumatol"},{"issue":"18","key":"10.1016\/j.rdc.2023.06.007_bib98","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.149185","article-title":"Th1 polarization defines the synovial fluid T\u00a0cell compartment in oligoarticular juvenile idiopathic arthritis","volume":"6","author":"Jule","year":"2021","journal-title":"JCI Insight"},{"issue":"5943","key":"10.1016\/j.rdc.2023.06.007_bib99","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1126\/science.1175870","article-title":"Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation","volume":"325","author":"Johnston","year":"2009","journal-title":"Science"},{"issue":"5943","key":"10.1016\/j.rdc.2023.06.007_bib100","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1126\/science.1176676","article-title":"Bcl6 mediates the development of T follicular helper cells","volume":"325","author":"Nurieva","year":"2009","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.rdc.2023.06.007_bib101","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.immuni.2009.07.002","article-title":"The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment","volume":"31","author":"Yu","year":"2009","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.007_bib102","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13073-018-0558-x","article-title":"Disease-specific regulation of gene expression in a comparative analysis of juvenile idiopathic arthritis and inflammatory bowel disease","volume":"10","author":"Mo","year":"2018","journal-title":"Genome Med"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.007_bib103","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13075-018-1603-2","article-title":"Transcription factor motif enrichment in whole transcriptome analysis identifies STAT4 and BCL6 as the most prominent binding motif in systemic juvenile idiopathic arthritis","volume":"20","author":"Hugle","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.rdc.2023.06.007_bib104","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1546-0096-12-28","article-title":"Development of positive antinuclear antibodies and rheumatoid factor in systemic juvenile idiopathic arthritis points toward an autoimmune phenotype later in the disease course","volume":"12","author":"Hugle","year":"2014","journal-title":"Pediatr Rheumatol Online J"},{"issue":"173","key":"10.1016\/j.rdc.2023.06.007_bib105","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005407","article-title":"CD19+CD24hiCD38hi B cells maintain regulatory T\u00a0cells while limiting TH1 and TH17 differentiation","volume":"5","author":"Flores-Borja","year":"2013","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.rdc.2023.06.007_bib106","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jdermsci.2015.11.003","article-title":"IL-10-producing regulatory B cells are decreased in patients with psoriasis","volume":"81","author":"Hayashi","year":"2016","journal-title":"J\u00a0Dermatol Sci"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.007_bib107","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jdermsci.2017.01.010","article-title":"Corrigendum to \"IL-10-producing regulatory B cells are decreased in patients with psoriasis\"","volume":"86","author":"Hayashi","year":"2017","journal-title":"J\u00a0Dermatol Sci"},{"issue":"32","key":"10.1016\/j.rdc.2023.06.007_bib108","doi-asserted-by":"crossref","first-page":"33486","DOI":"10.18632\/oncotarget.5588","article-title":"CD19(+)CD24(hi)CD38(hi)Bregs involved in downregulate helper T\u00a0cells and upregulate regulatory T\u00a0cells in gastric cancer","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.rdc.2023.06.007_bib109","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.4049\/jimmunol.1800468","article-title":"Insufficient IL-10 Production as a Mechanism Underlying the Pathogenesis of Systemic Juvenile Idiopathic Arthritis","volume":"201","author":"Imbrechts","year":"2018","journal-title":"J\u00a0Immunol"},{"issue":"12","key":"10.1016\/j.rdc.2023.06.007_bib110","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1136\/annrheumdis-2019-216040","article-title":"Emergent high fatality lung disease in systemic juvenile arthritis","volume":"78","author":"Saper","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.rdc.2023.06.007_bib111","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1002\/art.41073","article-title":"Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease: Characterization and Risk Factors","volume":"71","author":"Schulert","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.rdc.2023.06.007_bib112","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1136\/annrheumdis-2021-220578","article-title":"Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1\u221715 alleles","volume":"81","author":"Saper","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.rdc.2023.06.007_bib113","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1002\/art.41071","article-title":"Storm Warning: Lung Disease in Systemic Juvenile Idiopathic Arthritis","volume":"71","author":"Nigrovic","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2023.06.007_bib114","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/rheumatology\/kez284","article-title":"IL-18 as therapeutic target in a patient with resistant systemic juvenile idiopathic arthritis and recurrent macrophage activation syndrome","volume":"59","author":"Yasin","year":"2019","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.rdc.2023.06.007_bib115","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.clim.2015.06.005","article-title":"Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"160","author":"Shimizu","year":"2015","journal-title":"Clin Immunol"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.007_bib116","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/j.jaci.2016.10.022","article-title":"Life-threatening NLRC4-associated hyperinflammation successfully treated with IL-18 inhibition","volume":"139","author":"Canna","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.rdc.2023.06.007_bib117","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/annrheumdis-2017-212608","article-title":"Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease","volume":"77","author":"Gabay","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.007_bib118","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10875-022-01353-y","article-title":"Improvement of Refractory Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease with Single-Agent Blockade of IL-1beta and IL-18","volume":"43","author":"Rood","year":"2023","journal-title":"J\u00a0Clin Immunol"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.007_bib119","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1164\/rccm.201903-0659OC","article-title":"Synergistic TLR\/IFNalpha\/beta-Signaling Facilitates Escape of IL-18 Expression from Endotoxin Tolerance","volume":"201","author":"Verweyen","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.rdc.2023.06.007_bib120","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2845","article-title":"Tofacitinib Treatment of Refractory Systemic Juvenile Idiopathic Arthritis","volume":"143","author":"Huang","year":"2019","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.rdc.2023.06.007_bib121","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1136\/annrheumdis-2020-216983","article-title":"Effectiveness and safety of ruxolitinib for the treatment of refractory systemic idiopathic juvenile arthritis like associated with interstitial lung disease : a case report","volume":"81","author":"Bader-Meunier","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.007_bib122","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3899\/jrheum.100726","article-title":"Combination therapy of abatacept and anakinra in children with refractory systemic juvenile idiopathic arthritis: a retrospective case series","volume":"38","author":"Record","year":"2011","journal-title":"J\u00a0Rheumatol"},{"issue":"9636","key":"10.1016\/j.rdc.2023.06.007_bib123","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(08)60998-8","article-title":"Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial","volume":"372","author":"Ruperto","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.rdc.2023.06.007_bib124","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1136\/ard-2022-222849","article-title":"Secukinumab in enthesitis-related arthritis and juvenile psoriatic arthritis: a randomised, double-blind, placebo-controlled, treatment withdrawal, phase 3 trial","volume":"82","author":"Brunner","year":"2023","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X23000674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X23000674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:31:42Z","timestamp":1760182302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X23000674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":124,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0889857X23000674"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2023.06.007","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2023.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}